captopril (Capoten) reduces the risk of heart attack, stroke, and death in patients with hypertension

New evidence now suggests captopril (Capoten) reduces the riskof heart attack, stroke, and death in patients with hypertension.

This is important.

Up until now, only beta-blockers and diuretics have beenshown to reduce cardiovascular morbidity and mortality.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote